234 related articles for article (PubMed ID: 12544728)
1. Coagulation factor V G allele and HR2 haplotype: factor V activity, activated protein C resistance and risk of venous thrombosis.
Kostka H; Schwarz T; Schellong S; Mix C; Kuhlisch E; Temelkova-Kurktschiev T; Henkel E; Köhler C; Gehrisch S; Siegert G
Blood Coagul Fibrinolysis; 2003 Jan; 14(1):49-56. PubMed ID: 12544728
[TBL] [Abstract][Full Text] [Related]
2. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM
Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
[TBL] [Abstract][Full Text] [Related]
3. A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 Haplotype) polymorphisms.
Bouaziz-Borgi L; Nguyen P; Hezard N; Musharrafieh U; Almawi WY; Mahjoub T
Exp Mol Pathol; 2007 Dec; 83(3):480-3. PubMed ID: 17555744
[TBL] [Abstract][Full Text] [Related]
4. FV HR2 haplotype as additional inherited risk factor for deep vein thrombosis in individuals with a high-risk profile.
Margaglione M; Bossone A; Coalizzo D; D'Andrea G; Brancaccio V; Ciampa A; Grandone E; Di MG
Thromb Haemost; 2002 Jan; 87(1):32-6. PubMed ID: 11848454
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis.
Akhter MS; Biswas A; Ranjan R; Meena A; Yadav BK; Sharma A; Saxena R
Clin Appl Thromb Hemost; 2010 Apr; 16(2):184-8. PubMed ID: 19419975
[TBL] [Abstract][Full Text] [Related]
6. Factor V HR2 haplotype: a risk factor for venous thromboembolism in individuals with absence of Factor V Leiden.
Otrock ZK; Taher AT; Shamseddeen WA; Zaatari G; Bazarbachi A; Mahfouz RA
Ann Hematol; 2008 Dec; 87(12):1013-6. PubMed ID: 18654780
[TBL] [Abstract][Full Text] [Related]
7. Association of factor V deficiency with factor V HR2.
Faioni EM; Castaman G; Asti D; Lussana F; Rodeghiero F
Haematologica; 2004 Feb; 89(2):195-200. PubMed ID: 15003895
[TBL] [Abstract][Full Text] [Related]
8. Is homozygosity for the HR2 haplotype a risk factor for venous thromboembolism?
Aras O; Hanson NQ; Tsai MY; Key NS
Thromb Haemost; 2002 Jan; 87(1):173-4. PubMed ID: 11848451
[No Abstract] [Full Text] [Related]
9. Polymorphisms in the protein C gene as risk factor for venous thrombosis.
Pomp ER; Doggen CJ; Vos HL; Reitsma PH; Rosendaal FR
Thromb Haemost; 2009 Jan; 101(1):62-7. PubMed ID: 19132190
[TBL] [Abstract][Full Text] [Related]
10. The factor V R2 allele: risk of venous thromboembolism, factor V levels and resistance to activated protein C.
Luddington R; Jackson A; Pannerselvam S; Brown K; Baglin T
Thromb Haemost; 2000 Feb; 83(2):204-8. PubMed ID: 10739373
[TBL] [Abstract][Full Text] [Related]
11. Haplotypes of IL1B, IL1RN, IL1R1, and IL1R2 and the risk of venous thrombosis.
van Minkelen R; de Visser MC; Houwing-Duistermaat JJ; Vos HL; Bertina RM; Rosendaal FR
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1486-91. PubMed ID: 17413037
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of activated protein C resistance phenotype in subjects with compound heterozygosity for HR2 haplotype and FV Leiden mutation (R506Q) in factor V gene.
Castaman G; Ruggeri M; Tosetto A; Rodeghiero F
Thromb Haemost; 2000 Aug; 84(2):357-8. PubMed ID: 10959717
[No Abstract] [Full Text] [Related]
13. The factor V gene A4070G mutation and the risk of venous thrombosis.
Alhenc-Gelas M; Nicaud V; Gandrille S; van Dreden P; Amiral J; Aubry ML; Fiessinger JN; Emmerich J; Aiach M
Thromb Haemost; 1999 Feb; 81(2):193-7. PubMed ID: 10063990
[TBL] [Abstract][Full Text] [Related]
14. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.
Torres JD; Cardona H; Alvarez L; Cardona-Maya W; Castañeda SA; Quintero-Rivera F; Cadavid A; Bedoya G; Tobón L
Am J Hematol; 2006 Dec; 81(12):933-7. PubMed ID: 16917913
[TBL] [Abstract][Full Text] [Related]
15. Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism.
Bergrem A; Dahm AE; Jacobsen AF; Mowinckel MC; Sandvik L; Sandset PM
Br J Haematol; 2011 Jul; 154(2):241-7. PubMed ID: 21564075
[TBL] [Abstract][Full Text] [Related]
16. The HR2 haplotype of factor V is not associated with the risk of myocardial infarction.
Doggen CJ; de Visser MC; Vos HL; Bertina RM; Cats VM; Rosendaal FR
Thromb Haemost; 2000 Nov; 84(5):815-8. PubMed ID: 11127862
[TBL] [Abstract][Full Text] [Related]
17. [From gene to disease; risk factors for venous thrombosis: factor V Leiden and prothrombin 20210A].
Reitsma PH; van de Stolpe A
Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1843-5. PubMed ID: 11593787
[TBL] [Abstract][Full Text] [Related]
18. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.
Silingardi M; Salvarani C; Boiardi L; Accardo P; Iorio A; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Ciccia F; Ghirarduzzi A; Filippini D; Paolazzi G; Iori I
Arthritis Rheum; 2004 Apr; 51(2):177-83. PubMed ID: 15077257
[TBL] [Abstract][Full Text] [Related]
19. Cytokine gene variants and venous thrombotic risk in the BRATROS (BRAZILIAN THROMBOSIS STUDY).
Pieroni F; Lourenço DM; Morelli VM; Maffei FH; Zago MA; Franco RF
Thromb Res; 2007; 120(2):221-9. PubMed ID: 17113632
[TBL] [Abstract][Full Text] [Related]
20. Candidate gene approach in association studies: would the factor V Leiden mutation have been found by this approach?
van Hylckama Vlieg A; Sandkuijl LA; Rosendaal FR; Bertina RM; Vos HL
Eur J Hum Genet; 2004 Jun; 12(6):478-82. PubMed ID: 15054398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
